161 related articles for article (PubMed ID: 15200451)
1. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.
Rao M; Guo D; Jaber BL; Tighiouart H; Pereira BJ; Balakrishnan VS;
Kidney Int; 2004 Jul; 66(1):419-27. PubMed ID: 15200451
[TBL] [Abstract][Full Text] [Related]
2. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
3. Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.
Stefoni S; Cianciolo G; Donati G; Dormi A; Silvestri MG; Colì L; De Pascalis A; Iannelli S
Kidney Int; 2002 Jan; 61(1):324-35. PubMed ID: 11786115
[TBL] [Abstract][Full Text] [Related]
4. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
[TBL] [Abstract][Full Text] [Related]
5. Association of TGF-beta1 polymorphisms with chronic renal disease.
Coll E; Cormand B; Campos B; González-Núñez D; Iñigo P; Botey A; Poch E
J Nephrol; 2004; 17(6):794-9. PubMed ID: 15593053
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.
Heine GH; Ulrich C; Sester U; Sester M; Köhler H; Girndt M
Kidney Int; 2003 Sep; 64(3):1101-7. PubMed ID: 12911563
[TBL] [Abstract][Full Text] [Related]
7. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β1-gene polymorphism in the development of kidney disease after liver transplantation.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Bahra M; Neuhaus P; Schmitz V
Transplantation; 2012 Mar; 93(5):555-60. PubMed ID: 22366990
[TBL] [Abstract][Full Text] [Related]
9. Peripheral vascular disease severity impacts health outcomes and health-related quality of life in maintenance hemodialysis patients in the HEMO Study.
Liu T; Liang KV; Rosenbaum A; Stephenson R; Pike F; Weissfeld L; Unruh ML
Nephrol Dial Transplant; 2012 Jul; 27(7):2929-36. PubMed ID: 22273665
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
11. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
12. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
Baştürk B; Yavaşçaoğlu I; Vuruşkan H; Göral G; Oktay B; Oral HB
Cytokine; 2005 Apr; 30(1):41-5. PubMed ID: 15784411
[TBL] [Abstract][Full Text] [Related]
13. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
14. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation.
Holweg CT; Baan CC; Balk AH; Niesters HG; Maat AP; Mulder PM; Weimar W
Transplantation; 2001 May; 71(10):1463-7. PubMed ID: 11391236
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 gene polymorphisms in patients with end-stage heart failure.
Holweg CT; Baan CC; Niesters HG; Vantrimpont PJ; Mulder PG; Maat AP; Weimar W; Balk AH
J Heart Lung Transplant; 2001 Sep; 20(9):979-84. PubMed ID: 11557193
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
17. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
18. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection.
Pereira FA; Pinheiro da Silva NN; Rodart IF; Carmo TM; Lemaire DC; Reis MG
J Med Virol; 2008 Jan; 80(1):58-64. PubMed ID: 18041006
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese.
Hsu HJ; Yang YH; Shieh TY; Chen CH; Kao YH; Yang CF; Ko EC
Kaohsiung J Med Sci; 2015 Mar; 31(3):123-9. PubMed ID: 25744234
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.
Osterreicher CH; Datz C; Stickel F; Hellerbrand C; Penz M; Hofer H; Wrba F; Penner E; Schuppan D; Ferenci P
Cytokine; 2005 Jul; 31(2):142-8. PubMed ID: 15941661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
